Time to SARS‐CoV‐2 clearance among patients with cancer and COVID‐19

BACKGROUND: For cancer patients, coronavirus disease 19 (COVID‐19) infection can lead to delays in cancer therapy both due to the infection itself and due to the need to minimize exposure to other patients and to staff. Clearance guidelines have been proposed, but expected time to clearance has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenxin, Piper‐Vallillo, Andrew J., Bindal, Poorva, Wischhusen, Jonathan, Patel, Jaymin M., Costa, Daniel B., Peters, Mary Linton B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940218/
https://www.ncbi.nlm.nih.gov/pubmed/33560590
http://dx.doi.org/10.1002/cam4.3708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940218/
https://www.ncbi.nlm.nih.gov/pubmed/33560590
http://dx.doi.org/10.1002/cam4.3708

Ejemplares similares